MedTrace Logo

Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity

NCT04670328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2020-12-17

No results posted yet for this study

Summary

The hemostatic abnormalities in COVID-19 are related with disease progression, severity and mortality. The Objective of our study is to evaluate the role of hematological parameters in determination of COVID-19 disease severity.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

not required

Diagnostic tests( hematological parameters) were assessed.

Sponsors & Collaborators

  • FMH College of Medicine and Dentistry

    lead OTHER

Principal Investigators

  • Ayaz Lone, MBBS,FCPS · FMH College of Medicine and Dentistry

Eligibility

Min Age
17 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670328 on ClinicalTrials.gov